FeelTect has kicked off a clinical trial in Ireland to evaluate its wearable, pressure-sensing device for vein ulcers.
Researchers at the University of Galway will...
Boston Scientific announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system.
Watchman FLX, Boston Scientific’s left atrial appendage closure (LAAC) device, reduces...
iPerf announced the first-in-human use of its new dual-flow femoral arterial cannula device. Lyon, France-based iPerf designed its device to integrate an additional flow...
Providence Medical Technology has enrolled the first subjects in its prospective, randomised controlled trial (RCT) assessing the CORUS-LX system to treat degenerative lumbosacral disease.
The...
Senseonics announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM.
Real-world evidence demonstrated the long-term performance and positive...
Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study...
TECLens has commenced the first-in-human clinical trial assessing its quantitative corneal crosslinking (qCXL) technology for non-invasive refractive vision correction, administering treatment to the initial...
VESTECK announced that implanting clinicians will present two-year follow-up data from the company’s first-in-human experience with the SUTURE-TIGHT™ Endovascular Catheter System, an adjunctive fixation...
Kandu Health announced positive results from the first randomized controlled trial of its brain-computer interface (BCI) therapy.
The trial evaluated its FDA-cleared, non-invasive IpsiHand BCI...